These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11736909)

  • 1. Anaphylaxis to 5-methoxypsoralen during photochemotherapy.
    Legat FJ; Wolf P; Kränke B
    Br J Dermatol; 2001 Nov; 145(5):821-2. PubMed ID: 11736909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic actinic dermatitis: successful treatment with psoralen-ultraviolet A photochemotherapy.
    Chee SN; Novakovic L; Fassihi H; Garibaldinos T; Sarkany R
    Br J Dermatol; 2018 Mar; 178(3):e189-e190. PubMed ID: 28889653
    [No Abstract]   [Full Text] [Related]  

  • 3. Photoallergic dermatitis from 8-methoxypsoralen.
    Plewig G; Hofmann C; Braun-Falco O
    Arch Dermatol Res; 1978 Apr; 261(2):201-11. PubMed ID: 148873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin.
    González S; Pathak MA; Cuevas J; Villarrubia VG; Fitzpatrick TB
    Photodermatol Photoimmunol Photomed; 1997; 13(1-2):50-60. PubMed ID: 9361129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis from 5-methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis.
    Stephens RB; Cooper A
    Australas J Dermatol; 1999 Nov; 40(4):217-9. PubMed ID: 10570561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylaxis to 8-methoxypsoralen during photochemotherapy.
    Park JY; Rim JH; Choe YB; Youn JI
    Photodermatol Photoimmunol Photomed; 2003 Feb; 19(1):37-8. PubMed ID: 12713554
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
    Ravenscroft J; Goulden V; Wilkinson M
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S218-9. PubMed ID: 11712064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems posed by the therapeutic use of photosensitizers in dermatology].
    Beani JC; Amblard P; Reymond JL
    Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual cause of burn injury: unsupervised use of drugs that contain psoralens.
    Türegün M; Oztürk S; Selmanpakoğlu N
    J Burn Care Rehabil; 1999; 20(1 Pt 1):50-2. PubMed ID: 9934637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flu-like syndrome, bronchoconstriction and fever caused by 5-methoxypsoralen: the first case report and literature review.
    Mantovani L; Minghetti S; Maranini C; Furicchia G; Borghi A; Virgili A
    Dermatology; 2011; 223(3):213-5. PubMed ID: 21576926
    [No Abstract]   [Full Text] [Related]  

  • 12. PUVA therapy for photosensitive psoriasis.
    Ros AM; Wennersten G
    Acta Derm Venereol; 1987; 67(6):501-5. PubMed ID: 2451375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen.
    Berg M; Ros AM
    Photodermatol Photoimmunol Photomed; 1994 Oct; 10(5):217-20. PubMed ID: 7880762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.
    McNeely W; Goa KL
    Drugs; 1998 Oct; 56(4):667-90. PubMed ID: 9806110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
    Tanew A; Ortel B; Rappersberger K; Hönigsmann H
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement.
    Treffel P; Makki S; Humbert P; Khaldoun H; Agache P
    Acta Derm Venereol; 1992; 72(1):65-7. PubMed ID: 1350152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1977 Nov; 28(11):583-8. PubMed ID: 599020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course for development of psoralen plus ultraviolet A erythema following oral administration of 5-methoxypsoralen.
    Berroeta L; Attili S; Wong A; Man I; Dawe RS; Ferguson J; Ibbotson SH
    Br J Dermatol; 2009 Mar; 160(3):717-9. PubMed ID: 19183168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.